COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America-Reference-Cited by-同舟云学术

COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America

Published:2021-06 Issue: Volume:51 Page:102886
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Alonso Ricardo,Silva Berenice,Garcea Orlando,Diaz Patricio E. Correa,dos Passos Giordani Rodrigues,Navarro Deyanira A. Ramirez,Valle Luis A. Garcia,Salinas Luis C. Rodriguez,Negrotto Laura,Luetic Geraldine,Tkachuk Verónica A.,Míguez Jimena,de Bedoya Fernando Hamuy Diaz,Goiry Lorna Galleguillos^ORCID,Sánchez Nicia E. Ramírez,Burgos Marcos,Steinberg Judith,Balbuena Maria E.,Alvarez Priscilla Monterrey^ORCID,López Pablo A.,Ysrraelit María C.^ORCID,León Rosalba A.,Cohen Aron Benzadon,Gracia Fernando,Molina Omaira,Casas Magdalena,Deri Norma H.,Pappolla Agustín,Patrucco Liliana,Cristiano Edgardo,Tavolini Dario,Nadur Debora,Granda Ana M. Toral,Weiser Roberto,Cassará Fátima Pagani,Sinay Vladimiro,Rodríguez Claudia Cárcamo,Lazaro Luciana G.,Menichini María L.,Piedrabuena Raúl,Escobar Geraldine Orozco,Carrá Adriana,Chertcoff Anibal,Pujols Biany Santos,Vrech Carlos,Tarulla Adriana,Carvajal René^ORCID,Mainella Carolina,Becker Jefferson,Peeters Liesbet M.,Walton Clare,Serena Marina Alonso,Nuñez Sebastián,Rojas Juan I.

Funder

Biogen Inc

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference21 articles.

1. Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic;Brownlee,2020

2. COVID-19 in MS and NMOSD: A multicentric online national survey in Chile;Ciampi;Mult Scler Relat Disord,2020

3. Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder;Creed;Mult Scler Relat Disord,2020

4. Risk of COVID-19 infection in MS and neuromyelitis optica spectrum disorders;Fan;Neurol Neuroimmunol Neuroinflamm,2020

5. The COVID-19 pandemic and the use of MS disease-modifying therapies;Giovannoni;Mult Scler Relat Disord,2020

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study;Frontiers in Immunology;2024-08-19

2. Low-dose rituximab regimen does not increase severe COVID-19 risk in patients with neuroimmune diseases during the pandemic: a cross-sectional study;2024-07-29

3. Neuromyelitis Optica Spectrum Disorder in Latin America: State-of-the-Art and Current Challenges;Journal of Integrative Neuroscience;2024-04-07

4. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study;Journal of Clinical Medicine;2023-11-23

5. What might the COVID‐19 pandemic in regard to people with neuromyelitis optica spectrum disorder teach us regarding the future?;Clinical and Experimental Neuroimmunology;2023-10-08